CJC-1295
A growth-hormone-releasing hormone analog studied for its stimulation of growth hormone secretion.
Intended role: Provides the GHRH signaling component of the proposed performance and recovery concept.
Peptide Programs · peptide
CJC-1295 + Ipamorelin
Catalog reference only — current pharmacy label, exact strength and clinical approval pending.
A peptide program designed around recovery, body-composition and muscle-support goals.
This program groups related goals into an individual clinical discussion. The exact ingredient selection and formulation rationale will be explained after pharmacy confirmation; intended goals are not proven outcomes.
Recovery · Body composition · Muscle-support goals
CJC-1295 + Ipamorelin
Catalog reference only — current pharmacy label, exact strength and clinical approval pending.
A growth-hormone-releasing hormone analog studied for its stimulation of growth hormone secretion.
Intended role: Provides the GHRH signaling component of the proposed performance and recovery concept.
A growth hormone secretagogue acting through ghrelin-related receptors, a different pathway from CJC-1295.
Intended role: Adds a different growth hormone signaling pathway to that concept.
Product education reviewed by Dr. Rouzbeh Sattari — owner-reported verbal approval, October 8, 2026. Current pharmacy labeling and individual clinical approval must be confirmed before treatment. Ingredient names do not establish a dose, route or treatment recommendation.
Evidence, safety & treatment information ↗Share your goals, medical history and medications securely.
A licensed clinician reviews suitability, risks and alternatives.
If appropriate and available, an authorized order is reviewed manually. Direct pharmacy fulfillment can be connected after confirmation.
Ongoing clinical review guides monitoring and refill decisions.
Intended goals and biological mechanisms do not establish clinical outcomes for this formulation. Individual response varies; benefits are not guaranteed.
Intended program goals are not established outcomes for this formulation. Individual clinical review, verified formulation and lawful pharmacy availability are required. No dosing instructions are provided here.
Treatment requires individual medical evaluation and a prescription where applicable. It depends on clinician judgment, eligibility, and verified pharmacy and state availability. A program selection does not guarantee treatment.
Compounded medications are not FDA-approved; FDA does not review them for safety, effectiveness or quality before marketing. Approval or evidence for one ingredient or branded medicine does not establish the same for this formulation. Outcomes vary and are not guaranteed.
Discuss adverse effects, interactions, pregnancy or reproductive considerations and appropriate alternatives with your clinician. Formulation, route, dosing and monitoring must be confirmed before treatment.
Read the full medical & treatment information ↗No payment is taken in this website.
Peptide and weight-management programs: one simple, all-in price. Clinical consultation, medication, fulfillment, and required injection supplies included. Treatment is subject to clinical evaluation, eligibility and clinician approval; a prescription is not guaranteed.